Supernus Pharmaceuticals
SUPN
SUPN
225 hedge funds and large institutions have $1.67B invested in Supernus Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 74 increasing their positions, 85 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
1% more funds holding
Funds holding: 223 → 225 (+2)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
13% less repeat investments, than reductions
Existing positions increased: 74 | Existing positions reduced: 85
Holders
225
Holding in Top 10
3
Calls
$2.42M
Puts
$1.93M
Top Buyers
| 1 | +$36.5M | |
| 2 | +$13.4M | |
| 3 | +$10.9M | |
| 4 |
CAM
Congress Asset Management
Boston,
Massachusetts
|
+$9.08M |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
+$6.71M |
Top Sellers
| 1 | -$25.6M | |
| 2 | -$7.51M | |
| 3 | -$7.09M | |
| 4 |
Two Sigma Investments
New York
|
-$6.52M |
| 5 |
PP
Prudential plc
London, England,
United Kingdom
|
-$6.34M |